Clinical Cancer Research Grant

    From Rising Tide Foundation

    Rising Tide Foundation promotes freedom and prosperity for all, advocating for a market economy, limited government, and the rule of law. They believe in individual flourishing through voluntary exchange and aim to address poverty by respecting individual dignity and moral agency. Their goal is to support projects that eliminate obstacles for creative individuals, offering a "hand up" instead of a "hand-out," and oppose big-government and crony capitalism interventions.

    Type of Support

    Overview

    The grant program is guided by principles of patient involvement, aiming to establish a new norm in clinical cancer research that treats patients as partners. It supports interventional clinical trials not funded by commercial entities, with a requirement for research to show patient impact within 3 to 5 years and to start within 6 months of award notification. The funding approach is rooted in patient centricity, ensuring research aligns with improving patient quality of life. Projects should focus on short time frames for maximum impact, and align with strategic focus areas developed with expert input. These areas include improving patient outcomes with minimal toxicity, enhancing early detection and intervention, and advancing research in underserved regions. The foundation encourages partnerships to maximize reach and expects co-funding plans from applicants. Specific focus areas include therapy optimization, disease and treatment burden, implementation research, early detection, early intervention, and advancing cancer research in Sub-Saharan Africa.

    Eligibility

    Organization's Location
    et incididunt
    Program Location
    ex
    Organization Type
    Labore esse
    Incididunt nulla
    Other
    • est commodo quis Lorem enim elit duis
    • cillum tempor cupidatat consequat nostrud quis sit magna culpa consectetur enim esse
    • ut sit et in et pariatur excepteur aliqua commodo sit
    • magna fugiat quis exercitation laboris sunt cillum ad pariatur nisi dolore eiusmod
    • qui qui laboris mollit id pariatur est amet nisi do qui excepteur

    Submission

    Schedule
    Step 1: anim duis duis
    Application deadline
    Mar 24, 2026
    Step 2: nisi commodo (cupidatat dolor)